What is Heron Therapeuti?
, a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 48.04M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.